Effect of information about the benefits and harms of mammography on women's decision making: The InforMa randomised controlled trial
Pérez Lacasta, María José
Perestelo Pérez, Lilisbeth
Feijoo Cid, Maria
Toledo Chávarri, Ana
Carles Lavila, Misericordia
MetadataShow full item record
BACKGROUND: In Spain, women invited to breast screening are not usually informed about potential harms of screening. The objective of the InforMa study is to assess the effect of receiving information about the benefits and harms of breast screening on informed choice and other decision-making outcomes, in women approaching the age of invitation to mammography screening. METHODS: Two-stage randomised controlled trial. In the first stage, 40 elementary territorial units of the public healthcare system were selected and randomised to intervention or control. In the second stage, women aged 49-50 years were randomly selected. The target sample size was 400 women. Women in the intervention arm received a decision aid (DA) with detailed information on the benefits and harms of screening. Women in the control arm received a standard leaflet that did not mention harms and recommended accepting the invitation to participate in the Breast Cancer Screening Program (BCSP). The primary outcome was informed choice, defined as adequate knowledge and intentions consistent with attitudes. Secondary outcomes included decisional conflict, worry about breast cancer, time perspective, opinions about the DA or the leaflet, and participation in the BCSP. RESULTS: In the intervention group, 23.2% of 203 women made an informed choice compared to only 0.5% of 197 women in the control group (p < 0.001). Attitudes and intentions were similar in both study groups with a high frequency of women intending to be screened, 82.8% vs 82.2% (p = 0.893). Decisional conflict was significantly lower in the intervention group. No differences were observed in confidence in the decision, anxiety, and participation in BCSP. CONCLUSIONS: Women in Spain lack knowledge on the benefits and harms of breast screening. Providing quantitative information on benefits and harms has produced a considerable increase in knowledge and informed choice, with a high acceptance of the informative materials. TRIAL REGISTRATION: Trial identifier NCT03046004 at ClinicalTrials.gov registry. Registered on February 4 2017. Trial name: InforMa study.
Is part ofPlos One, 2019, vol. 14, núm. 3, p. e0214057
European research projects
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by (c) Pérez Lacasta, María José et al., 2019
Showing items related by title, author, creator and subject.
The effect of information about the benefits and harms of mammography on women’s decision-making: study protocol for a randomized controlled trial Misericòrdia, Carles; Martínez Alonso, Montserrat; Pons Rodríguez, Anna; Pérez Lacasta, María José; Perestelo Pérez, Lilisbeth; Sala, Maria; Vidal, Carmen; Garcia, Montse; Toledo Chávarri, Ana; Codern, Núria; Feijoo Cid, Maria; Romero, Anabel; Pla, Roger; Soler González, Jorge; Castells, Xavier; Rué i Monné, Montserrat (BioMed Central, 2017)The decision to participate or not in breast cancer screening is complex due to the trade-off between the expected benefit of breast cancer mortality reduction and the major harm of overdiagnosis. It seems ethically necessary ...
Assessment of the effects of decision aids about breast cancer screening: a systematic review and meta-analysis Martínez Alonso, Montserrat; Carles Lavila, Misericordia; Pérez Lacasta, María José; Pons Rodríguez, Anna; Garcia, Montse; Rué i Monné, Montserrat (BMJ Publishing Group, 2017)The aim of this systematic review and meta-analysis of randomised controlled trials (RCTs) and observational studies is to assess the effect of decision aids (DAs) in women aged 50 and below facing the decision to be ...
Evolución de la mortalidad por cáncer de mama y diseminación de la mamografía de cribado en Cataluña: un análisis por regiones sanitarias Pérez Lacasta, María José; Gregori Gomis, Aleix; Carles Lavila, Misericordia; Gispert i Magarolas, Rosa; Martínez Alonso, Montserrat; Vilaprinyo Terré, Ester; Pla Farnós, Roger; Rué i Monné, Montserrat (Espanya. Ministerio de Sanidad y Consumo, 2010)Fundamento: El descenso de las tasas de mortalidad por cáncer de mama (CM) se ha atribuido a la implantación de programas de cribado y a avances terapéuticos. El objetivo de este trabajo es comparar la evolución de su ...